March 17, 2009 - Basilea Pharmaceutica Ltd. announces that Toctino (alitretinoin), a new once-daily oral treatment for adults with severe chronic hand eczema (CHE) unresponsive to potent topical corticosteroids, has been approved by the Austrian Agency for Health and Food Safety (AGES).
The details can be read here.
No comments:
Post a Comment